White House preps to pump bil­lions in­to mR­NA vac­cine man­u­fac­tur­ing ca­pac­i­ty — but Mod­er­na and Pfiz­er will have to buy in

The White House re­leased ear­ly de­tails this week on its plan to pump bil­lions of new dol­lars in mR­NA vac­cine man­u­fac­tur­ing to in­crease the num­ber of dos­es abroad and pre­pare for the next pan­dem­ic too.

“Im­por­tant­ly, ini­tial pro­duc­tion could pro­vide more mR­NA COVID vac­cines for the world,” coro­n­avirus re­sponse co­or­di­na­tor Jef­frey Zients said Thurs­day at a me­dia brief­ing. “The goal of this pro­gram is to ex­pand ex­ist­ing ca­pac­i­ty by an ad­di­tion­al bil­lion dos­es per year, with pro­duc­tion start­ing by the sec­ond half of 2022.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER